Rising Aging Population and Increasing Healthcare Expenditure is Likely to Drive the Clinical Chemistry Analyzers Industry

Growth in the clinical chemistry analyzer market is primarily driven by increasing incidents for medical help majorly due to ageing population and aiding medical insurance programs. Chronic diseases like diabetes, cancer, obesity, cardiovascular diseases and auto immune diseases like infections and influenza are the major causes of mortality worldwide. Ageing population attracts many health related issues worldwide, currently translating to 7% proportion of elderly increase. The growing affordability for getting better medical assistance also leads to growth for this market.

The increasingly aging population in the region has given humongous scope for medical companies to expand in the coming years. According to World Health Organisation (WHO), an average age for having any sort of medical problem is 60 years.  In addition, the latest data indicates that in the North American and Caribbean regions in 2011, an estimated 37.7 million people were diagnosed with diabetes, and this figure is expected to increase enormously in the coming years. In 2012, about 29.1 million that is 9.3% of the total population in North America suffered from diabetes. The U.S. has recorded the highest number of people diagnosed with diabetes, followed by Mexico and Canada. All these factors act as essential market drivers for the clinical chemistry analyzers markets.

In 2010, after adjusting for population age differences, hospitalization rates for heart attack were 1.8 times higher among adults within the age group of 20 years or older with diagnosed diabetes, than among adults without diagnosed diabetes.

In-depth profiling of the key players have been conducted along with the recent developments ( New product launches and partnerships, investments, collaborations and mergers and acquisitions) and strategies adopted by them to sustain in the Americas clinical chemistry analyzers market. F. Hoffmann La-Roche Ltd., Beckmann Coulter Inc., Ortho-clinical diagnostics Inc., Abbott Laboratories, and Siemens Healthcare are some of the key players operating in this market.

Leave a Comment